Abstract. Obesity and inflammation are known to correlate with the pathogenesis of obstructive sleep apnea syndrome (OSAS). Interleukin (IL)-6, an important regulator of obesity and inflammation, was reported to phenotypically increase in patients with OSAS. This study aimed to investigate whether genetic variants in IL-6 confer susceptibility to OSAS. The study population consisted of 151 patients with OSAS and 75 healthy controls from Southeast China. Five haplotype-tagging single nucleotide polymorphisms (tSNPs) were selected across 21 kb of the IL-6 locus using Haploview software V4.1. The tSNPs were amplified by polymerase chain reaction (PCR) and genotyped by restriction enzyme digestion followed by gel electrophoresis. Linkage disequilibrium (LD) and haplotype reconstruction were carried out by means of a SHEsis program. No distribution difference of any of the five tSNPs between OSAS patients and controls was observed. However, in nonobese individuals (n=117), the minor allele G (rs1800796) decreased risk of OSAS compared with the major allele C [odds ratio (OR), 0.48; 95% confidence interval (CI), 0.26-0.86; p=0.014], and the haplotype TG (rs1880242, rs1800796) conferred a significantly decreased risk of OSAS than single allele G (rs1800796) (OR, 0.39; 95% CI, p=0.003). Moreover, the severity of sleep-disordered breathing (measured by apnea hypopnea index) increased linearly in carriers of the C variant of IL-6 -572G/C polymorphism (14.3±5.1, 22.0±3.6 and 34.8±3.5 for GG, CG and CC, respectively; p=0.012). To the best of our knowledge, this is the first study to suggest that genetic variants in IL-6 could modify OSAS susceptibility. SNP genotyping of IL-6 is a potential strategy for detecting the risk of breathing disordered diseases in non-obese individuals.
Introduction
Obstructive sleep apnea syndrome (OSAS) is defined as repeated episodes of obstructive apnea and hypopnea during sleep, together with daytime excessive sleepiness or altered cardiopulmonary function (1, 2) . OSAS has emerged as a major public health problem with the middle-aged population and obesity epidemic (3) . Obesity is a strong risk factor for OSAS, and it is hypothesized that genetic variants predisposed to obesity facilitate the development of OSAS (4) . Furthermore, the inflammatory process is activated in the pathogenesis of OSAS. Polymorphisms of several inflammation-associated genes, including angiotensin converting enzyme gene (ACE) (5) , tumor necrosis factor-alpha gene (TNF-·) (6) , and insulin receptor substrate gene (IRS) (7) , correlate with OSAS, suggesting that inflammation is also implicated in the pathogenesis of this complex syndrome.
Interleukin-6 (IL-6), produced by many different kinds of cells in the body, is one of the most important mediators of inflammatory response (8) , and plays either a pro-or antiinflammatory role (9) . There are increasing experimental data showing that three SNPs -174G/C (rs1800795), -572C/G (rs1800796) and -6331T/C (rs10499563) and several haplotypes of the IL-6 gene are not only related to levels of plasma IL-6 but also to inflammation (10) (11) (12) (13) (14) . Moreover, the IL-6 gene polymorphism is suggested to participate in the pathogenesis of obesity and modify the risk of developing obesity-related metabolic disorders, especially insulin resistance (15, 16) . Herein, genetic variants in the IL-6 gene play an important role in the pathogenesis of OSAS. However, the IL-6 gene is not genetically associated with OSAS.
Considering the notion that association studies based on haplotypes instead of genotypes, significantly improves the power of mapping and characterizing disease-causing genes (17) . We hypothesized that genetic variants in IL-6, comprised of polymorphisms and haplotypes, confer susceptibility to OSAS. Therefore, we employed linkage disequilibrium (LD) and haplotype-based analyses to address the hypothesis using five tagging SNPs (tSNPs) selected from across 21 kb of the IL-6 locus and haplotypes reconstructed with the tSNPs in 226 participants of the Han Chinese population. As a result, our data suggest that genetic variants in IL-6 play important roles in modifying the susceptibility to OSAS.
Materials and methods

Subjects.
One-hundred and fifty-one patients with OSAS and 75 age-matched controls were enrolled after informed consent from unrelated, ethnic Han Chinese subjects. Patients were recruited from the Department of Respiratory Medicine at the First Affiliated Hospital of Soochow University between July 2005 and November 2007. Controls were sleep disorderfree individuals that were enrolled in the same region. All subjects received an examination of standard overnight polysomnography (PSG) before they were classified into case and control groups, according to the criteria of Riha (6) regarding apnea hypopnea index (AHI). All the subjects were classified into two sub-groups according to a body mass index (BMI) cut-off point of 27 kg/m 2 (18) , obese group [BMI ≥27, including OSAS patients (n=90) and controls (n=19)] and non-obese group [BMI <27, including OSAS patients (n=61) and controls (n=56)]. This study was approved by the ethics committee at the participating institution and the Academic Advisory Board of Soochow University.
Polysomnography. Physiological examinations of all the subjects were recorded with overnight PSG (Rembrandt Monet-32, Medcare Inc, Reykjavik, Iceland). Electroencephalography, electromyography, electrocardiography and electrooculography were performed with surface electrodes. Ventilatory movements of chest and abdomen were monitored using inductive plethysmography. Nasal and oral airflow were explored with thermistors. Arterial oxygen saturation (Sao 2 ) was measured by finger pulse oximetry. Apnea was defined as continuous cessation of airflow for more than 10 sec while hypopnea was referred to as at least 50% of reduction in flow for more than 10 sec with oxygen desaturation of ≥4%. AHI was calculated as the total number of apneas and hypopneas per hour of sleep.
Tagging SNPs selection. HapMap SNP database (www. hapmap.org) and National Center for Biotechnology Information database (www.ncbi.nlm.nih.gov/dbSNP) were used to explore SNPs among the Han Chinese population. Twenty-four SNPs were obtained from 11 kb upstream of the transcriptional start site to 5 kb downstream of the IL-6 3'-UTR. Minor allele frequency (MAF) >0.05 was allocated for capturing the entire common SNPs. The tSNPs were selected using Haploview software V4.1 on the basis of their pairwise LD with the r 2 threshold of 0.8. Of 14 frequently identified SNPs, five tSNPs ( Fig. 1) that represent all the common SNPs in the IL-6 region were selected for association study.
Genotyping. Genomic DNA was isolated from blood samples according to standard proteinase K digestion and phenolchloroform extraction (19) . Five tSNPs of the IL-6 gene were amplified by polymerase chain reaction (PCR). Primer sequence sets and various annealing temperatures for PCR are given in Table I . Each PCR was carrried out in a total volume of 25 μl containing 50-100 ng genomic DNA, 1 unit Ex Taq DNA polymerase (Takara, Japan), 0.2 μmol/l of each primer, 1 x Ex Taq Buffer (Mg 2+ Plus) and 0.25 mmol/l of each dNTP. The tSNPs were screened through restriction fragment length polymorphism with restriction endonucleases (Table I) . Genotyping was done using 12% polyacrylamide gel electrophoresis followed by visualization with ethidium bromide.
LD and haplotype analysis. Lewontin coefficient (D') and squared correlation coefficient (r 2 ) for pairwise LD of the five tSNPs were calculated with a SHEsis program (20) . Reconstructing haplotypes with the genotyping data was performed using a Full-Precise-Iteration algorithm of SHEsis, given that haplotypes with a frequency of <0.05 were not considered in the analysis.
Statistical analysis.
Results are presented as mean ±SE. Comparisons between groups were performed with independent t or ANOVA tests for continuous variables. Statistical analyses for genetics were applied to differentiate distribution of frequency for genotypes, alleles and haplotypes between OSAS patients and controls. Hardy-Weinberg equilibrium (HWE) analysis for genotype distribution in controls, was carried out by a Pearson's goodness-of-fit Chisquare test. Difference of genotype and allele frequencies between cases and controls were determined using Chi-square test or Fisher's exact test. Logistic regression was performed to assess odds ratios (OR) and 95% confidence intervals (CI), which were adjusted for gender, age and BMI. All the statistical analyses above were implemented with SPSS 16.0 for Windows (SPSS Inc, Chicago, IL). Haplotype distribution difference between cases and controls was analyzed using SHEsis program. All statistical analyses are for two-sided tests, and considered significant at p<0.05.
Results
Characteristics of OSAS and control subjects. The characteristics of 151 patients with OSAS and 75 healthy controls are shown in Table II . BMI and polysomnographic parameters of OSAS patients were significantly higher than those of controls, respectively (p<0.001). Compared to normal weight, overweight and obesity conferred 2.94-fold (95% CI, 1.00-8.64) and 9.09-fold (95% CI, 3.07-26.92) increased risk of OSAS, respectively (Table III) . This suggests that BMI increment is positively associated with increased risk of OSAS. In total, obese individuals (BMI ≥27) had a 3.84-fold (95% CI, 2.02-7.29) increased risk of OSAS compared to the nonobese (BMI <27), including the normal and the overweight.
Frequency distributions for genotype and allele.
Frequency distributions for all genotypes of five SNPs were not deviated from HWE in controls (data not shown). No distribution difference of genotypes or alleles between 151 patients with OSAS and 75 healthy controls was found (Table IV) . After stratifying by BMI, we did not find the significant difference between obese OSAS patients and obese controls. However, the frequency of IL-6 -572G (rs1800796) was remarkably Table I . Primers and restriction endonucleases used for genotyping IL-6 gene. 
a FR, forward primer; RP, reverse primer.
b The polymorphic alleles are identified and digested by restriction endonucleases at the specific sites of PCR products.
- Fig. 2a ).
IL-6 -572G/C polymorphism, BMI and severity of sleepdisordered breathing.
To analyze whether IL-6 -572G/C polymorphism modifies the risk of obesity and severity of sleepdisordered breathing, we performed independent ANOVA tests among individuals with three genotypes (GG, CG and CC). As shown in Fig. 3a , mean BMI did not present significant differences according to the individuals carrying any of the three genotypes of IL-6 -572G/C polymorphism in both the OSAS (p=0.661) and healthy control groups (p=0.552), indicating that the influence of this polymorphism on OSAS developing was independent of BMI. In non-obese individuals (n=117), the severity of sleep-disordered breathing (measured 
a Data are presented as mean ±SE. Most subjects were male. BMI, body mass index; AHI, apnea hypopnea index; AI, apnea index; % Sao 2 <90%, percentage of total sleep time with Sao 2 <90%; b p-values were calculated by independent-samples t-test.
- ------------------------------------------------ by AHI) increased linearly in carriers of the C variant of IL-6 -572G/C polymorphism (14.3±5.1, 22.0±3.6 and 34.8±3.5 for GG, CG and CC, respectively; p=0.012). However, there was no significant difference in severity of sleep-disordered breathing between obese individuals carrying the three genotypes (n=109, p=0.559, Fig 3b) .
Haplotype analysis. Pairwise LD of the five tSNPs is shown in Fig. 2b . Two polymorphisms, rs1404008 and rs1880242, were in strong LD among OSAS patients (D', 1.0; r 2 , 0.9) and healthy controls (D', 1.0; r 2 , 1.0). Furthermore, LD between these two SNPs and the other three SNPs (rs10499563, rs1800796 and rs2069837) was extremely similar in both cases and controls. Therefore, four tSNPs (rs1880242, rs10499563, rs1800796 and rs2069837) were selected for haplotype construction.
To assess whether various haplotypes consisting of at least two of the four tSNPs contributed to risk of OSAS, we performed OR analyses in cases and controls. As shown in Table V , when haplotypes comprising of any two of the four tSNPs were reconstructed, the frequencies for haplotype TC (rs18800242 and rs1800796) and CC (rs10499563 and rs1800796) were significantly higher in OSAS patients ( ] . In contrast, the haplotype TG (rs1880242, rs1800796) had a protective effect (OR, 0.39, 95% CI, 0.20-0.74), which was compatible with a hazardous effect of haplotype TC (rs18800242 and rs1800796) in non-obese OSAS. The results suggest that these three haplotypes are significantly associated with modified risk of non-obese OSAS (p=0.020, p=0.022 and p=0.003, respectively). ----------------------------------------------------------------------------------------------------- a Data are presented based on the cut-off point for overweight and obesity in CHB population with a BMI of 23 and 27 kg/m 2 , respectively; b OR, 95% CI and p-values were from logistic regression, adjusted for age and gender. 
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Frequency differences of genotype and allele between cases and controls were compared by¯2 or Fisher's exact tests. OR and 95% CI were from logistic regression, adjusted for age, gender and BMI; b p<0.05.
-----------------------------------------------------------------------------------------------------------------------------------------------------
Discussion
This is the first study to provide evidence that susceptibility to OSAS is influenced by genetic variants in IL-6. Using a haplotype-tagging SNPs approach, we identified the G allele of rs1800796 (-572C/G) in the promoter region of IL-6 associated with reduced risk of developing non-obese OSAS, and the severity of sleep-disordered breathing increased linearly in carriers of the C variant of IL-6 -572G/C polymorphism in non-obese individuals. Furthermore, our results suggest that several haplotypes play various roles in modifying the predisposition of OSAS in the Chinese population. OSAS is now recognized as a major public health problem in the world. It increases risk of stroke and morbidity and mortality of hypertension and cardiovascular diseases (21-23). Large-scale epidemiological studies on OSAS suggest a conservatively estimated prevalence of 2-4% in middle-aged Caucasian and Chinese populations (3, 24, 25) . Preferential understanding of how OSAS develops and progresses will yield important clues to diagnosis and prevention as well as treatment for OSAS. Obesity is one of the strongest risk factors for developing OSAS (3, 4) . Meanwhile, clinical and fundamental studies suggest that inflammation involves the pathogenesis of OSAS (5) (6) (7) 26, 27 ) and IL-6 was reported to phenotypically increase in patients with OSAS (28) (29) (30) . In an attempt to elucidate the relationship between genetic variants in the IL-6 gene and OSAS, we provided two aspects of support with a population-based study.
First, we performed an investigation on the relationship between obesity, IL-6 and OSAS, based on the fact that overweight and obesity are strong risk factors for OSAS. The results show that being overweight or obese increases risk of OSAS more than 2-and 9-fold, respectively, compared to being normal weight. This is in accordance with previously reported data from other groups (3, 31) . Although genetic variants that predispose obesity facilitate the development of OSAS, polymorphisms of several obesity-related genes, including ß 3 -adrenergic receptor (ADRB3) (32) , Leptin, and leptin receptor (LEPR) genes (33), are not suggested to associate with OSAS. In the present study, we found that -572G/C polymorphism of IL-6 gene is associated with OSAS susceptibility and severity of sleep-disordered breathing in non-obese subjects, suggested that SNP genotyping of IL-6 gene is a potential strategy for detecting the risk of breathing disordered diseases in non-obese individuals. Notably, the polymorphisms of the ADRB3 gene favor the development of obesity in patients who already suffer OSAS (32) . However, no polymorphisms of IL-6 related to obesity, either in OSAS patients or healthy controls, were found in our investigation.
Wallenius et al demonstrated that IL-6 knockout mice developed mature-onset obesity with disturbed carbo-hydrate and lipid metabolism, increased leptin levels and decreased responsiveness to leptin treatment (34) , suggesting that IL-6 deficiency leads to obesity-related diseases. Moreover, an in vitro functional study indicated that genetic polymorphisms in the promoter influenced IL-6 transcription not by a simple additive mechanism, but through complex interactions determined by the haplotype (35) . It is helpful to understand our findings that the haplotypes TC (rs1880242 and rs1800796) and CC (rs10499563 and rs1800796) confer increased risk of OSAS in the Chinese population.
Second, we focused on understanding whether modified risk for non-obese OSAS was attributable to genetic variants of IL-6. Intriguingly, -572G allele of IL-6 significantly conferred a protective effect on OSAS in the non-obese population. A recently reported function concerning -572G that reduces transcriptional activity of the IL-6 promoter furthers our understanding of how it decreases risk of OSAS (13) . More importantly, the haplotype TG (rs1880242 and rs1800796) of IL-6, carried by 30.3% of non-obese controls and 14.4% of cases, made a more protective contribution to OSAS than a single polymorphism -572G. Given that IL-6 down-regulates 
All subjects Non-obese subjects Obese subjects -------------------------------------------------------------------------------------------------- a Only the common haplotypes, frequencies of >5%, in CHB and significantly different between cases and controls, were included; b four tSNPs alleles that lined from left to right (rs1880242, rs10499563, rs1800796 and rs2069837) were used for haplotype reconstruction; c haplotype frequencies (%) in OSAS and controls; d 0.01<p<0.05; e p=0.003; ~, represents variable alleles of certain specific tSNP; -, not included due to frequency <5%.
-----------------------------------------------------------------------------------------------------
the synthesis of IL-1 and TNF, and play anti-inflammatory roles in several complex diseases (9, 36, 37) , the haplotype TG decreases the risk of non-obese OSAS by influencing an antiinflammation pathway in the Chinese population. Oppositely, we found that it increases the risk of OSAS, when assessing the association of this haplotype with OSAS in obese subjects (Table V) . Therefore, we do not exclude the possibility that obesity diminishes the protective effect of the haplotype TG on OSAS.
However, our estimates will likely show ethnic differences and require confirmation in various types of populations. In support of this, an exemplified genetic variant, polymorphism -174G/C of IL-6 promoter (rs1800795), is prone to a wide variety of diseases in the European population (10, (38) (39) (40) while it presents null heterozygous in the Chinese population. Unfortunately, no report on whether this polymorphism confers the risk of OSAS was documented in the European population.
In summary, to the best of our knowledge, this is the first study to suggest that genetic variants in IL-6 modify OSAS susceptibility in the Chinese population. The -572G/C polymorphism of the IL-6 gene is associated with OSAS susceptibility and severity of sleep-disordered breathing in non-obese individuals. Furthermore, several haplotypes play various roles in modifying the predisposition of OSAS in the Chinese population. Genotyping of the IL-6 gene is a potential strategy for detecting the risk of breathing disordered diseases in non-obese individuals.
